Alessandra Vultaggio to Cohort Studies
This is a "connection" page, showing publications Alessandra Vultaggio has written about Cohort Studies.
Connection Strength
0.043
-
Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS). J Clin Immunol. 2018 07; 38(5):602-609.
Score: 0.034
-
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FceRI. Eur J Immunol. 2018 12; 48(12):2005-2014.
Score: 0.009